- Home
- CRL vs BXSL Comparison
CRL vs BXSL Comparison
Compare CRL & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- BXSL
- Stock Information
- Founded
- CRL 1947
- BXSL 2018
- Country
- CRL United States
- BXSL United States
- Employees
- CRL N/A
- BXSL N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- CRL Health Care
- BXSL Finance
- Exchange
- CRL Nasdaq
- BXSL Nasdaq
- Market Cap
- CRL 7.1B
- BXSL 7.3B
- IPO Year
- CRL 2000
- BXSL N/A
- Fundamental
- Price
- CRL $157.12
- BXSL $31.23
- Analyst Decision
- CRL Hold
- BXSL Buy
- Analyst Count
- CRL 14
- BXSL 6
- Target Price
- CRL $186.38
- BXSL $31.38
- AVG Volume (30 Days)
- CRL 859.6K
- BXSL 944.7K
- Earning Date
- CRL 08-06-2025
- BXSL 08-06-2025
- Dividend Yield
- CRL N/A
- BXSL 9.87%
- EPS Growth
- CRL N/A
- BXSL N/A
- EPS
- CRL N/A
- BXSL 3.14
- Revenue
- CRL $4,022,597,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- CRL N/A
- BXSL $9.58
- Revenue Next Year
- CRL $2.49
- BXSL $3.71
- P/E Ratio
- CRL N/A
- BXSL $9.94
- Revenue Growth
- CRL N/A
- BXSL 16.76
- 52 Week Low
- CRL $91.86
- BXSL $25.89
- 52 Week High
- CRL $254.15
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- CRL 67.60
- BXSL 46.47
- Support Level
- CRL $148.41
- BXSL $30.40
- Resistance Level
- CRL $160.40
- BXSL $31.06
- Average True Range (ATR)
- CRL 4.71
- BXSL 0.45
- MACD
- CRL 0.42
- BXSL -0.10
- Stochastic Oscillator
- CRL 81.08
- BXSL 41.85
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.